Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-04-05FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2016-04-05FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for metformin hydrochloride from Granules Pharmaceuticals Inc., authorizing an additional formulatio…
-
FDA approval · 2016-04-05FDA Approved: ALOGLIPTIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for ALOGLIPTIN filed by Padagis Israel Pharmaceuticals Ltd, authorizing changes to an existing alogl…
-
FDA approval · 2016-04-05FDA Approved: KAZANO — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Kazano (alogliptin and metformin hydrochloride) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2016-04-05FDA Approved: ALOGLIPTIN AND PIOGLITAZONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved a supplemental application for the alogliptin benzoate and pioglitazone hydrochloride combination product from Padagis Isra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-03-28FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Invokana (canagliflozin) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2016-03-28FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA Supplemental Approval for INVOKAMET (canagliflozin and metformin hydrochloride) by Janssen Pharmaceuticals, Inc. The action approves a l…
-
FDA approval · 2016-03-24FDA Approved: ACARBOSE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for ACARBOSE from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2016-03-17FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVOKAMET (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2016-03-17FDA Approved: ALOGLIPTIN AND PIOGLITAZONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved a supplemental application for a fixed-dose combination of alogliptin benzoate and pioglitazone hydrochloride to treat type…
-
FDA approval · 2016-02-29FDA Approved: GLYBURIDE AND METFORMIN HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved a generic Glyburide and Metformin Hydrochloride tablet under an Original Application (ANDA) by Zydus Pharmaceuticals (USA) Inc.
-
FDA approval · 2016-02-16FDA Approved: TOUJEO — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Toujeo (insulin glargine) submitted by Sanofi-Aventis U.S. LLC. The approval pertains to cha…
-
FDA approval · 2016-02-11FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for JENTADUETO, the fixed-dose combination of linagliptin and metformin hydrochloride, submitted by …
-
FDA approval · 2016-01-26FDA Approved: PIOGLITAZONE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for Pioglitazone from NorthStar RxLLC, authorizing the generic product under ANDA 202467.
-
FDA approval · 2016-01-12FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the fixed-dose combination of dapagliflozin and metformin hydrochloride submitted by Prasco …
-
FDA approval · 2016-01-12FDA Approved: JARDIANCE — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approves a supplemental application for Jardiance (empagliflozin) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2016-01-11FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUVIA (sitagliptin) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2016-01-08FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN R (human insulin) submitted by Novo Nordisk. The action represents regulatory approv…
-
FDA approval · 2016-01-08FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk.
-
FDA approval · 2016-01-05FDA Approved: GLYBURIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for glyburide from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. for an existing gly…
-
FDA approval · 2016-01-05FDA Approved: GLIPIZIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for GLIPIZIDE from Actavis Pharma, Inc., enabling continued marketing of the generic drug.
-
FDA approval · 2015-12-23FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKAMET, the fixed-dose combination of canagliflozin and metformin hydrochloride, submitte…
-
FDA approval · 2015-12-16FDA Approved: BASAGLAR KWIKPEN — Original Application (Eli Lilly and Company)
FDA approved BASAGLAR KWIKPEN (insulin glargine) by Eli Lilly in an Original Application as a long-acting insulin for glycemic control in ad…
-
FDA approval · 2015-12-04FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a dapagliflozin and metformin hydrochloride product.
-
FDA approval · 2015-12-04FDA Approved: GLYXAMBI — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for GLYXAMBI (empagliflozin and linagliptin) from Boehringer Ingelheim Pharmaceuticals, Inc.